Showing results (11-20 of 53) with videos related to
Sort By:
Pageof 6
Kidney International|June 16, 2011
Erythropoiesis-stimulating agents and pure red-cell aplasia: you can't fool Mother NatureJay B WishKidney International|June 30, 2012
A physician's perseverance uncovers problems in a key nephrology studySteven Fishbane, Jay B WishAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 1, 2017
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Potential New Treatment for Anemia in Patients With CKDNupur Gupta, Jay B WishClinical Journal of the American Society of Nephrology : CJASN|July 15, 2020
Strategies to Reduce Rehospitalization in Patients with CKD and Kidney FailureSimit Doshi, Jay B WishCurrent Opinion in Nephrology and Hypertension|May 11, 2018
Erythropoietin mimetic peptides and erythropoietin fusion proteins for treating anemia of chronic kidney diseaseNupur Gupta, Jay B WishSeminars in Dialysis|February 27, 2018
Do current quality measures truly reflect the quality of dialysis?Nupur Gupta, Jay B WishAdvances in Chronic Kidney Disease|September 4, 2019
The Evolution of Target Hemoglobin Levels in Anemia of Chronic Kidney DiseaseJonathan Bazeley, Jay B WishClinical Journal of the American Society of Nephrology : CJASN|July 18, 2015
Quality Measurement in Wonderland: The Curious Case of a Dialysis Readmissions MeasureSteven Fishbane, Jay B WishAdvances in Chronic Kidney Disease|December 12, 2018
Leading the Dialysis Unit: Role of the Medical DirectorSharmeela Saha, Jay B WishMayo Clinic Proceedings. Innovations, Quality & Outcomes|October 24, 2022
Evolution of Mineralocorticoid Receptor Antagonists in the Treatment of Chronic Kidney Disease Associated with Type 2 Diabetes MellitusJay B Wish, Pablo PergolaPageof 6